Interesting facts
Interesting Facts about 3-[2-hydroxy-5-(trifluoromethyl)phenyl]-6-(trifluoromethyl)-1H-benzimidazol-2-one
This intriguing compound, known for its multifaceted chemical structure, belongs to the benzimidazole family, which is renowned for its diverse biological activities.
Key Highlights:
- Fluorinated Phenyl Groups: The presence of two trifluoromethyl groups enhances the compound's lipophilicity, making it quite significant in pharmaceutical nomenclature. These groups can greatly influence the molecular interactions in biological systems, enhancing efficacy and bioavailability.
- Potential Applications: Due to its unique molecular characteristics, this compound shows promising potential in medicinal chemistry. It may act as a candidate for drug development, particularly in targeting specific receptors or enzymes.
- Biological Activity: Compounds featuring the benzimidazole moiety often exhibit an array of biological functions, including but not limited to:
- Antimicrobial properties
- Anticancer activities
- Antiparasitic effects
- Versatile Synthesis: The synthetic pathways for benzimidazole derivatives are well-established, enabling chemists to tweak the structure of this compound for desired properties. This flexibility allows for the design of targeted therapeutic agents.
Quote:
"The trifluoromethyl group is a chemical engineer's dream; it increases electron-withdrawing capability, enhancing reactivity and selectivity." – Chemistry Enthusiast
The structural complexity of 3-[2-hydroxy-5-(trifluoromethyl)phenyl]-6-(trifluoromethyl)-1H-benzimidazol-2-one illustrates the fascinating interplay between structure and activity in chemical compounds, paving the way for future discoveries in the realms of chemistry and pharmacology.
Synonyms
153587-01-0
NS-1619
NS 1619
1-(2-hydroxy-5-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-1H-benzo[d]imidazol-2(3H)-one
NS1619
1,3-Dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2H-benzimidazol-2-one
C15H8F6N2O2
3-[2-hydroxy-5-(trifluoromethyl)phenyl]-6-(trifluoromethyl)-1H-benzimidazol-2-one
CHEMBL384903
CHEBI:34879
MFCD00928190
1-(2'-Hydroxy-5'-trifluoromethylphenyl)-5-trifluoromethyl-2(3H)-benzimidazolone
1-(2-hydroxy-5-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-1,3-dihydro-2H-benzo[d]imidazol-2-one
1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-1,3-dihydro-2h-benzimidazol-2-one
DTXSID80165363
2H-Benzimidazol-2-one, 1,3-dihydro-1-(2-hydroxy-5-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-
5-trifluoromethyl-2,3-dihydro-1-(5-trifluoromethyl-2-hydroxyphenyl)-1H-2-oxo-benzimidazole
1,3-dihydro-1-(2-hydroxy-5-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-2H-Benzimidazol-2-one
1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2,3-dihydro-1H-1,3-benzodiazol-2-one
3-(2-hydroxy-5-(trifluoromethyl)phenyl)-6-(trifluoromethyl)-1H-benzimidazol-2-one
1-(2-hydroxy-5-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-1,3-dihydro-2H-benzimidazol-2-one
1-(2-hydroxy-5-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-2,3-dihydro-1H-1,3-benzodiazol-2-one
1-[2-HYDROXY-5-(TRIFLUOROMETHYL)PHENYL]-5-(TRIFLUOROMETHYL)-3H-1,3-BENZODIAZOL-2-ONE
NS 1619, powder
Lopac-N-170
Lopac0_000892
BSPBio_001425
KBioGR_000145
KBioSS_000145
MLS002172485
GTPL4272
SCHEMBL2820871
DTXCID6087854
BCBcMAP01_000241
KBio2_000145
KBio2_002713
KBio2_005281
KBio3_000289
KBio3_000290
Bio2_000145
Bio2_000625
HMS1361H07
HMS1791H07
HMS1989H07
HMS2233C07
HMS3262D06
HMS3374I04
HMS3402H07
BCP23926
EX-A3548
Tox21_500892
BDBM50347497
HB1048
KC-127
AKOS016007330
CCG-204974
CS-3613
LP00892
SDCCGSBI-0050867.P002
1-(2-Hydroxy-5-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-1H-benzo[d]imid azol-2(3H)-one
IDI1_033895
NCGC00015720-01
NCGC00015720-02
NCGC00015720-03
NCGC00015720-04
NCGC00015720-05
NCGC00015720-06
NCGC00015720-07
NCGC00015720-11
NCGC00094210-01
NCGC00094210-02
NCGC00094210-03
NCGC00094210-04
NCGC00261577-01
AC-35355
AS-55902
HY-12496
NS-1619?
SMR001254108
DB-043194
EU-0100892
N-170
N1191
SR-01000075337
SR-01000075337-1
BRD-K54210043-001-02-0
Q27088047
1-(2-Hydroxy-5-trifluoromethylphenyl)-5-trifluoromethyl-1,3-dihydro-2H-benzimidazol-2-one
1,3-Dihydro-1-[2-hydroxy-5-(trifluo romethyl)phenyl]-5-(trifluoromethyl)-2H-benzimidazol-2-one
Solubility of 3-[2-hydroxy-5-(trifluoromethyl)phenyl]-6-(trifluoromethyl)-1H-benzimidazol-2-one
The solubility of the compound 3-[2-hydroxy-5-(trifluoromethyl)phenyl]-6-(trifluoromethyl)-1H-benzimidazol-2-one (C16H10F6N2O2) is influenced by its unique molecular structure, which includes several trifluoromethyl groups and a hydroxyl group. The presence of these functional groups plays a critical role in its behavior in different solvents.
Factors Affecting Solubility:
While quantitative solubility data may not be readily available, it is essential to consider the balance between its polar and non-polar characteristics. This balance makes predicting the solubility behavior of the compound complex and highlights the need for experimental validation to determine its solubility profile in various media.